These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 35191342

  • 21. Bone-seeking radiopharmaceuticals as targeted agents of osteosarcoma: samarium-153-EDTMP and radium-223.
    Anderson PM, Subbiah V, Rohren E.
    Adv Exp Med Biol; 2014; 804():291-304. PubMed ID: 24924181
    [Abstract] [Full Text] [Related]

  • 22. Survival benefit with radium-223 dichloride in a mouse model of breast cancer bone metastasis.
    Suominen MI, Rissanen JP, Käkönen R, Fagerlund KM, Alhoniemi E, Mumberg D, Ziegelbauer K, Halleen JM, Käkönen SM, Scholz A.
    J Natl Cancer Inst; 2013 Jun 19; 105(12):908-16. PubMed ID: 23682134
    [Abstract] [Full Text] [Related]

  • 23. Fracture risk and survival outcomes in metastatic castration-resistant prostate cancer patients sequentially treated with abiraterone acetate and RADIUM-223.
    Caffo O, Frantellizzi V, Tucci M, Galli L, Monari F, Baldari S, Masini C, Bortolus R, Facchini G, Alongi P, Agostini S, Zichi C, Biasco E, Fanti S, Pignata S, Filice A, Borsatti E, Rossetti S, Spada M, Cortesi E, De Vincentis G.
    Eur J Nucl Med Mol Imaging; 2020 Oct 19; 47(11):2633-2638. PubMed ID: 32249345
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. The Curies' element: state of the art and perspectives on the use of radium in nuclear medicine.
    Franchi S, Asti M, Di Marco V, Tosato M.
    EJNMMI Radiopharm Chem; 2023 Nov 10; 8(1):38. PubMed ID: 37947909
    [Abstract] [Full Text] [Related]

  • 32. Real-time scintigraphic assessment of intravenous radium-223 administration for quality control.
    Wright CL, Monk JP, Murrey DA, Hall NC.
    Biomed Res Int; 2015 Nov 10; 2015():324708. PubMed ID: 25789312
    [Abstract] [Full Text] [Related]

  • 33. Hematologic Toxicity From Radium-223 Therapy for Bone Metastases in Castration-Resistant Prostate Cancer: Risk Factors and Practical Considerations.
    Jacene H, Gomella L, Yu EY, Rohren EM.
    Clin Genitourin Cancer; 2018 Aug 10; 16(4):e919-e926. PubMed ID: 29678471
    [Abstract] [Full Text] [Related]

  • 34. S-values for radium-223 and absorbed doses estimates for 223RACL2 using three computational phantoms.
    Silva CCO, da Silva AX, Braz D, Lima LFC, Segars WP, de Sá LV.
    Appl Radiat Isot; 2022 Nov 10; 189():110387. PubMed ID: 36137481
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. 223Ra Therapy of Advanced Metastatic Castration-Resistant Prostate Cancer: Quantitative Assessment of Skeletal Tumor Burden for Prognostication of Clinical Outcome and Hematologic Toxicity.
    Fosbøl MØ, Petersen PM, Kjaer A, Mortensen J.
    J Nucl Med; 2018 Apr 10; 59(4):596-602. PubMed ID: 28864632
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Progress in Targeted Alpha-Particle-Emitting Radiopharmaceuticals as Treatments for Prostate Cancer Patients with Bone Metastases.
    Patel CM, Wadas TJ, Shiozawa Y.
    Molecules; 2021 Apr 09; 26(8):. PubMed ID: 33918705
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.